Healthcare
April 5, 2018 / 9:41 AM / a year ago

BRIEF-CO DON: Successful Conclusion Of Phase II Trial 'co.dis'

1 Min Read

April 5 (Reuters) - Co Don AG:

* CONCLUSION OF PHASE II TRIAL ‘CO.DIS’ DEMONSTRATES EFFICACY AND SAFETY OF EU-AUTHORISED PHARMACEUTICAL PRODUCT SPHEROX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below